Patents by Inventor J. Turner

J. Turner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Analysis alternates in context trees
    Patent number: 7518749
    Abstract: A system, method, data structure, and application programming interface is described that stores alternate recognition results in an ink tree lattice.
    Type: Grant
    Filed: November 12, 2004
    Date of Patent: April 14, 2009
    Assignee: Microsoft Corporation
    Inventors: Richard J. Duncan, Jamie N. Wakeam, Zoltan C. Szilagyi, Jerome J. Turner, Timothy H. Kannapel, Subha Bhattacharyay
  • Albumin Fusion Proteins
    Publication number: 20090093402
    Abstract: The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.
    Type: Application
    Filed: October 30, 2007
    Publication date: April 9, 2009
    Applicants: Human Genome Sciences, Inc., Delta Biotechnology Limited
    Inventors: Craig A. Rosen, William A. Haseltine, David J. Ballance, Andrew J. Turner, Steven M. Ruben
  • Method of Generating a Non-Plugging Hydrate Slurry
    Publication number: 20090078406
    Abstract: Method for reducing loss of flow due to hydrate solids deposits and wax deposition in a pipeline without the aid of chemicals and system for transporting a flow of wellstream hydrocarbons containing water, using a main pipeline and a cold-flow reactor connected to the main pipeline or within or forming a part of the pipeline, wherein at least a portion of the wellstream is fed to the cold-flow reactor. Also provided is a method for preventing hydrate nucleation and growth in a pipeline and preventing hydrate agglomeration as well as for preventing wax deposition. The provided method eliminates the use of energized equipment for melting, grinding or scraping hydrate solids from inside of pipelines or flowlines. Generating dry hydrates to be mixed with main flow of a wellstream is also described.
    Type: Application
    Filed: February 22, 2007
    Publication date: March 26, 2009
    Inventors: Larry D. Talley, Douglas J. Turner, Douglas K. Priedeman
  • Albumin fusion proteins
    Patent number: 7507414
    Abstract: The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.
    Type: Grant
    Filed: March 14, 2005
    Date of Patent: March 24, 2009
    Assignee: Human Genome Sciences, Inc.
    Inventors: Craig A. Rosen, Homayoun Sadeghi, Christopher P. Prior, Andrew J. Turner
  • WEIGH ON THE FLY
    Publication number: 20090071728
    Abstract: Methods and apparatus for weighing an article, such as a mail piece, while the article is moving, for example along a transport path (FIG. 2). In one embodiment, a weigh station comprises a servo motor 110 driven by a servo feed back loop (126, 128) to maintain a selected speed setting 130. When an article is introduced, an impulse is applied to the article sufficient to change its state of motion from its initial state to the selected speed setting. That impulse is applied by the servo motor 110, and the system captures data indicative of the applied impulse, by monitoring the motor current (140, 142). A processor 140 or software converts the captured data to determine a weight of the article, based on stored calibration data 148.
    Type: Application
    Filed: September 13, 2007
    Publication date: March 19, 2009
    Applicant: RAF Technology, Inc.
    Inventor: Bryan J. Turner
  • Albumin fusion proteins
    Patent number: 7482013
    Abstract: The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention,as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.
    Type: Grant
    Filed: March 14, 2005
    Date of Patent: January 27, 2009
    Assignees: Human Genome Sciences, Inc., Delta Biotechnology Limited
    Inventors: David J. Ballance, Darrell Sleep, Christopher P. Prior, Homayoun Sadeghi, Andrew J. Turner
  • PROCESSES FOR CONVERTING GASEOUS ALKANES TO LIQUID HYDROCARBONS
    Publication number: 20090005620
    Abstract: A process for converting gaseous alkanes to olefins, higher molecular weight hydrocarbons or mixtures thereof wherein a gaseous feed containing alkanes is reacted with a dry bromine vapor to form alkyl bromides and hydrobromic acid vapor. The mixture of alkyl bromides and hydrobromic acid is then reacted over a suitable catalyst at a temperature sufficient to form olefins, higher molecular weight hydrocarbons or mixtures thereof and hydrobromic acid vapor. Various methods are disclosed to remove the hydrobromic acid vapor from the higher molecular weight hydrocarbons, to generate bromine from the hydrobromic acid for use in the process, and to selectively form monobrominated alkanes in the bromination step.
    Type: Application
    Filed: June 13, 2008
    Publication date: January 1, 2009
    Applicant: MARATHON GTF TECHNOLOGY, LTD.
    Inventors: John J. Waycuilis, William J. Turner
  • Albumin Fusion Proteins
    Publication number: 20080269125
    Abstract: The present invention encompasses albumin fusion proteins. Nucleic acid molecules encodings the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the intention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.
    Type: Application
    Filed: October 29, 2007
    Publication date: October 30, 2008
    Inventors: David J. Ballance, Darrell Sleep, Christopher P. Prior, Homayoun Sadeghi, Andrew J. Turner
  • Use of an Adhesive as an Intestinal Barrier for Bariatrics
    Publication number: 20080269715
    Abstract: An apparatus for achieving weight loss in a patient is disclosed. The apparatus has a barrier material and an applicator for dispensing the barrier material about the intestine. An injector is used to place the barrier material to block nutrient transfer from the intestine into the blood stream. The barrier material is a polymerizable adhesive that can be injected interstitially between layers of the intestine, or injected into vascular structures to partially block the flow of blood to the nutrient absorbing layers.
    Type: Application
    Filed: October 4, 2006
    Publication date: October 30, 2008
    Inventors: Craig N. Faller, Robert W. Scott, Bennie Thompson, Wells D. Haberstich, Anil K. Nalagatla, Douglas J. Turner, Donna L. Korvick, Frederick E. Shelton
  • Albumin Fusion Proteins
    Publication number: 20080267962
    Abstract: The present invention encompasses albumin fusion proteins. Nucleic acid molecules encodings the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the intention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.
    Type: Application
    Filed: October 29, 2007
    Publication date: October 30, 2008
    Inventors: David J. Ballance, Darrell Sleep, Christopher P. Prior, Homayoun Sadeghi, Andrew J. Turner
  • Albumin Fusion Proteins
    Publication number: 20080269127
    Abstract: The present invention encompasses albumin fusion proteins. Nucleic acid molecules encodings the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the intention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.
    Type: Application
    Filed: October 29, 2007
    Publication date: October 30, 2008
    Inventors: David J. Ballance, Darrell Sleep, Christopher P. Prior, Homayoun Sadeghi, Andrew J. Turner
  • Albumin Fusion Proteins
    Publication number: 20080269128
    Abstract: The present invention encompasses albumin fusion proteins. Nucleic acid molecules encodings the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the intention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.
    Type: Application
    Filed: October 29, 2007
    Publication date: October 30, 2008
    Inventors: David J. Ballance, Darrell Sleep, Christopher P. Prior, Homayoun Sadeghi, Andrew J. Turner
  • Albumin Fusion Proteins
    Publication number: 20080269126
    Abstract: The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.
    Type: Application
    Filed: October 29, 2007
    Publication date: October 30, 2008
    Inventors: David J. Ballance, Darrell Sleep, Christopher P. Prior, Homayoun Sadeghi, Andrew J. Turner
  • Albumin Fusion Proteins
    Publication number: 20080261877
    Abstract: The present invention encompasses albumin fusion proteins. Nucleic acid molecules encodings the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the intention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.
    Type: Application
    Filed: October 29, 2007
    Publication date: October 23, 2008
    Inventors: David J. Ballance, Darrell Sleep, Christopher P. Prior, Homayoun Sadeghi, Andrew J. Turner
  • Adaptive sampling for procedural graphics
    Patent number: 7414623
    Abstract: Techniques and tools for rendering procedural graphics are described. For example, an architecture is provided which allows evaluation of geometric, transform, texture, and shading procedures locally for a given set of procedure parameter values. This evaluation is performed in parallel for different parameter values on a single-instruction, multiple-data array to allow parallel processing of a procedure set. In another example, a sampling controller is described which selects sets of parameter points for evaluation based on information in tag maps, rate maps, and parameter maps.
    Type: Grant
    Filed: June 29, 2005
    Date of Patent: August 19, 2008
    Assignee: Microsoft Corporation
    Inventors: J. Turner Whitted, James T. Kajiya
  • Calibration of a focus error signal gain in a focus servo system
    Patent number: 7414940
    Abstract: A calibration of a focus error signal gain in a focus servo system of an optical disk drive is presented. The focus error signal gain can be calibrated by oscillating an optical pick-up unit in a focus direction through a focus point and determining a focus sum threshold. The optical pick-up unit can then be oscillated around a focus control effort that results in a sum signal equal to the focus sum threshold and the peak-to-peak value of a focus error signal can be measured. The focus error signal gain can be determined from the peak-to-peak value of the focus error signal.
    Type: Grant
    Filed: September 10, 2001
    Date of Patent: August 19, 2008
    Assignee: DPHI Acquisitions, Inc.
    Inventors: Ron J. Kadlec, Hans B. Wach, Christopher J. Turner
  • Albumin Fusion Proteins
    Publication number: 20080167238
    Abstract: The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.
    Type: Application
    Filed: October 30, 2007
    Publication date: July 10, 2008
    Applicants: Human Genome Sciences, Inc., Delta Biotechnology Limited
    Inventors: Craig A. Rosen, William A. Haseltine, David J. Ballance, Andrew J. Turner, Steven M. Ruben
  • Albumin Fusion Proteins
    Publication number: 20080167239
    Abstract: The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.
    Type: Application
    Filed: October 30, 2007
    Publication date: July 10, 2008
    Applicants: Human Genome Sciences, Inc., Delta Biotechnology Limited
    Inventors: Craig A. Rosen, William A. Haseltine, David J. Ballance, Andrew J. Turner, Steven M. Ruben
  • Albumin Fusion Proteins
    Publication number: 20080167240
    Abstract: The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.
    Type: Application
    Filed: October 30, 2007
    Publication date: July 10, 2008
    Applicants: Human Genome Sciences, Inc., Delta Biotechnology Limited
    Inventors: Craig A. Rosen, William A. Haseltine, David J. Ballance, Andrew J. Turner, Steven M. Ruben
  • Albumin Fusion Proteins
    Publication number: 20080161243
    Abstract: The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.
    Type: Application
    Filed: October 30, 2007
    Publication date: July 3, 2008
    Applicants: Human Genome Sciences, Inc., Delta Biotechnology Limited
    Inventors: Craig A. Rosen, William A. Haseltine, David J. Ballance, Andrew J. Turner, Steven M. Ruben